Intelligent Bio Solutions reports preliminary Q1 FY2026 revenue over $1M, up ~32% sequentially

INTELLIGENT BIO SOLUTIONS INC.

2026-Q1 EPS reported -$0.35 revenue$1,111,797

Preliminary revenue >$1M for fiscal Q1 ended Sep 30, 2025; third consecutive quarter of growth.
Revenue up ~32% sequentially and ~28% year-over-year.
Cartridge revenue up ~43% YoY; reader revenue up ~23% YoY.
Growth driven by new customer accounts and strong sales of both cartridges and readers.
Full Q1 financial results expected in 10-Q filing week of Nov 10, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.